Abstract
Background: Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition that has been the subject of extensive research, including studies using magnetic resonance imaging (MRI) to explore brain metabolites as potential biomarkers. Methods: The objective of our study was to identify brain metabolites using magnetic resonance and proton spectroscopy that could serve as potential markers of ASD (Autism Spectrum Disorder). Results: Magnetic resonance imaging did not reveal any brain morphological changes in ASD patients. However, the patients with ASD exhibited an elevated glutamate peak in 100% of cases. Conclusions: Magnetic resonance imaging combined with cerebellar spectroscopy is an emerging tool for the diagnosis and management of autism. This approach shows promise in enhancing both the diagnosis and treatment of ASD.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
